Drug Type AAV based gene therapy  | 
Synonyms CLX-004, CLX-01  | 
Target-  | 
Action-  | 
Mechanism-  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePendingPreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Fibrosis | Preclinical | United States   | 21 Aug 2021 | 





